Efficacy of red-light photodynamic therapy with 10% ALA gel in relation to the epidermal extent of atypical keratinocytes in actinic keratosis - Retrospective exploratory analysis of three pivotal phase III trials

Main Article Content

E Bierhoff
JL Cohen
RM Szeimies
U Reinhold
T Dirschka

Keywords

actinic keratosis, efficacy, red-light photodynamic therapy, 10% ALA gel, atypical keratinocytes, phase 3, clinical trial

References

1. Olsen EA, Abernethy ML, Kulp-Shorten C, et al., J Am Acad Dermatol 1991;24(5 Pt 1):738–43. PubMed PMID: 1869646

2. Schmitz L, Kahl P, Majores M, et al., J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1303-7. PMID: 26955898

3. Roewert-Huber J, Patel MJ, Forschner T, et al., Br J Dermatol 2007;156 Suppl 3:8–12. PubMed PMID: 17488400

4. Cockerell CJ. J Am. Acad. Dermatol 2000;42(1 Pt 2):11–7. PubMed PMID: 10607351

5. Clinical Study Report (ALA-AK-CT002), study design and results can be accessed via clinicaltrials.gov

6. Clinical Study Report (ALA-AK-CT003), study design and results can be accessed via clinicaltrials.gov

7. Clinical Study report (ALA-AK-CT007), study design and results can be accessed via clinicaltrials.gov

8. AMELUZ® (prescribing information). Woburn, MA: Biofrontera Inc.; 2021

9. Maisch T, Santarelli F, Schreml S, et al., Exp Dermatol. 2010; Aug;19(8):e302-5. doi: 10.1111/j.1600-0625.2009.01001.x. PMID: 19845760

Most read articles by the same author(s)